Oscar Health, Inc. cash flow to debt ratio of 254.56% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Oscar Health, Inc.'s free cash flow has increased 11.38% from $950.30M last year to $1.06B, signaling increasing performance

Oscar Health, Inc.'s debt to equity ratio is 0.21, which means that the company's assets are healthy financed, signaling financial stability.

Oscar Health, Inc.'s debt has decreased relative to shareholder equity from 0.30 last year to 0.21 today, signaling strengthened financials

Oscar Health, Inc. has a net cash position, so leverage is healthy.

Oscar Health, Inc.'s interest coverage ratio of 39.37 indicates that earnings with good margin can cover interest payments on company debt

Oscar Health, Inc.'s profit margin has increased (1.20K%) in the last year from 0.28% to 3.60%, signaling increasing performance

Oscar Health, Inc.'s short-term liabilities of $4.86B exceed its short-term assets of $4.61B, signaling financial risk

Oscar Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Oscar Health, Inc.'s return on equity of 38.53%, is higher than 15.00%, indicating good performance

Oscar Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Oscar Health, Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Oscar Health, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Oscar Health, Inc. has a free cash flow yield of 14.75%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Oscar Health, Inc.'s yearly earnings has decreased 1.84K% since last year from $25.43M to $-443.15M, signaling decreasing performance

Oscar Health, Inc.'s yearly revenue has increased 27.50% since last year from $9.18B to $11.70B, signaling increasing performance

ROIC 22.98% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Oscar Health, Inc.'s 3-year revenue CAGR of 41.55% is positive, indicating growing revenue over the past 3 years

Oscar Health, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Oscar Health, Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Oscar Health, Inc. is undervalued relative to its fair value price of 81.51 based on Discounted Cash Flow model

Oscar Health, Inc. has an earnings yield of 6.59%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Oscar Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Oscar Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Oscar Health, Inc. has insufficient data to evaluate this check.

Oscar Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Oscar Health, Inc. has a price-to-book ratio of 4.07x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Oscar Health, Inc. has a price-to-sales ratio of 0.55x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue